Intervention

Intervention group

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 23 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials23

Recruiting2

Common conditions25

Lead sponsors shown15

Clinical trials

23 shown

Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 AgonistNCT07718724 · 2026-09-05

Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.NCT05036590 · 2022-04-05

Nephroprotective Effects of Fig (Ficus Carica L.) Leaf SupplementationNCT07718880 · 2025-09-18

Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney DiseaseNCT06330480 · 2025-05-14

ENROLLING_BY_INVITATION

CARDIOCARE Prospective Clinical StudyNCT06334445 · 2023-09-14

A COPD Quality Improvement Program（QIP）NCT05638646 · 2022-11-25

PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study)NCT05319145 · 2022-05-01

Influence of Regular Physical Activity on Sleep in Patients With COPD and Idiopathic Lung FibrosisNCT05087017 · 2021-02-20

A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease PreventionNCT04545489 · 2020-12-01

Diabetes Nutrition Education With Glycemic ControlNCT04440319 · 2020-07-01

Efficacy of an App for Monitoring Physical Activity and Weight of Obese Pregnant Women (Pas&Pes)NCT03706872 · 2018-07-01

Multidisciplinary Treatment of Obesity Prior to in Vitro Fertilization: Impact on Global Reproductive Outcomes (PRO-FIV Study)NCT03395067 · 2018-01-28

Effects of the Administered Time of Meal on the Treatment of Overweight and ObesityNCT03347942 · 2017-08-10

Treatment of Overweight in General PracticeNCT03000062 · 2017-01-01

Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer SurvivorsNCT03095664 · 2016-11-01

Managing Adolescent Obesity at Local Level by Combining Primary and Secondary InterventionNCT02711488 · 2016-03-01

A Behavior Intervention Study on Cardiovascular Health Among Chinese Obese SchoolchildrenNCT02773823 · 2015-11-01

Healthy Mom Zone: A Gestational Weight Gain Management InterventionNCT03945266 · 2014-07-08

SORT - AF Supervised Obesity Reduction Trial for AF Ablation PatientsNCT02064114 · 2014-01-01

A Technology-Based Intervention for the Reduction of Overweight and Obesity Among College StudentsNCT02196012 · 2013-09-01

A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's DiseaseNCT01757509 · 2012-12-01

Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations PreventionNCT01282359 · 2011-10-01

Mobile Sipoo - Telemonitoring With Combined With Active Assistance TechnologyNCT01547156 · 2011-05-01

Common conditions

Leading sponsors

Hospital Clinic of Barcelona 2 Andalas University 1 AstraZeneca 1 Brazilian National Cancer Institute 1 Cliniques universitaires Saint-Luc- Université Catholique de Louvain 1 European Institute of Oncology 1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1 Hôpital le Vinatier 1 Hospital de Clinicas de Porto Alegre 1 Hospital Universitari Vall d'Hebron Research Institute 1 Penn State University 1 Prof. Dr. Folkert W. Asselbergs 1 Rio de Janeiro State University 1 Shenzhen People's Hospital 1 The University of Tennessee, Knoxville 1

Trial status mix

COMPLETED12

UNKNOWN6

RECRUITING2

ENROLLING_BY_INVITATION1

SUSPENDED1

TERMINATED1

Phase mix

NA20

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.